We previously described an increased frequency of CD3+ T lymphocytes and CD19+ B cells in anti-PD-1 responding tongue tumors, whereas, in tdLNs, only T cell frequencies but not B cells were higher in therapy–responding mice compared to non-responders [35]. Here, CD19 is linked to tongue neoplasm.